ZIOP Shares Outstanding History



Below is a table of the ZIOP shares outstanding history going back to 3/17/2010:

Date ZIOP Shares Outstanding
3/17/201041.57M
4/23/201041.77M
7/27/201048.83M
11/1/201048.56M
2/25/201165.75M
4/29/201166.34M
7/27/201168.40M
10/28/201168.45M
2/15/201279.47M
4/23/201279.52M
7/29/201279.57M
10/26/201279.62M
2/22/201383.70M
5/1/201383.56M
7/31/201383.52M
10/14/201383.70M
2/10/2014100.56M
4/30/2014100.73M
7/31/2014100.74M
10/30/2014102.71M
2/10/2015114.69M
5/1/2015128.23M
7/25/2015130.85M
10/26/2015130.89M
2/10/2016131.72M
4/26/2016131.84M
8/9/2016131.73M
11/3/2016131.73M
2/6/2017132.38M
4/24/2017132.38M
7/24/2017141.96M
10/31/2017141.96M
2/21/2018142.40M
4/17/2018142.65M
4/24/2018142.40M
7/24/2018142.38M
10/31/2018142.38M
2/21/2019162.29M
4/30/2019162.39M
7/24/2019162.55M
10/31/2019181.03M
2/14/2020213.00M
4/24/2020214.29M
7/31/2020214.15M
10/29/2020214.29M
2/24/2021214.67M
4/30/2021215.53M
7/31/2021215.56M
10/29/2021216.15M

Also see: ZIOP Market Cap History
ZIOP YTD Return
ZIOP Historical Shares Outstanding:
+15.23% CAGR
ZIOP Historical Shares Outstanding: +15.23% CAGR

Mouse over chart for data details
3/17/2010 ...10/29/2021
ZIOPHARM Oncology is a biopharmaceutical company focused on discovering, developing and commercializing immuno-oncology platforms that utilize cell- and gene-based therapies to treat patients with cancer. Co.'s primary platform is referred to as Sleeping Beauty and is based on the non-viral genetic engineering of immune cells using a transposon/transposase system that is intended to stably engineer T cells outside of the body for subsequent infusion. Co.'s second platform is referred to as Controlled IL-12 and is designed to stimulate expression of interleukin 12, a master regulator of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. We show 49 historical shares outstanding datapoints in our coverage of ZIOP's shares outstanding history.

Understanding the changing numbers of ZIOP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ZIOP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ZIOP by allowing them to research ZIOP shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ZIOP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ZIOPHARM Oncology (ZIOP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ZNTL Shares Outstanding History
ZSAN Shares Outstanding History
ZTS Shares Outstanding History
ZVRA Shares Outstanding History
ZY Shares Outstanding History
ZYME Shares Outstanding History
ZYNE Shares Outstanding History
ZYXI Shares Outstanding History
A Shares Outstanding History
AAC Shares Outstanding History
More Healthcare companies »

 

ZIOP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.